Mar 12 |
Rigel Pharmaceuticals appoints Lisa Rojkjaer, M.D. as CMO
|
Mar 12 |
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
|
Mar 7 |
Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year
|
Mar 7 |
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
|
Mar 6 |
Q4 2023 Rigel Pharmaceuticals Inc Earnings Call
|
Mar 6 |
Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),
|
Mar 6 |
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2023 Earnings Call Transcript
|
Mar 5 |
Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4
|
Mar 5 |
Rigel Pharmaceuticals GAAP EPS of $0.00 beats by $0.02, revenue of $35.8M beats by $2.39M
|
Mar 5 |
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|